A detailed history of Mesirow Financial Investment Management, Inc. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 14,536 shares of RLAY stock, worth $69,772. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,536
Holding current value
$69,772
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$6.23 - $9.51 $90,559 - $138,237
14,536 New
14,536 $102,000
Q2 2024

Jul 16, 2024

BUY
$5.9 - $8.02 $104,235 - $141,689
17,667 New
17,667 $115 Million
Q1 2024

Apr 19, 2024

BUY
$7.5 - $12.07 $132,202 - $212,757
17,627 New
17,627 $146 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $577M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.